Conditionally replicative adenovirus-based mda-7/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin

TERT'srole in colorectal carcinogenesis

(2012) Andrew J. Pellatt et al.   MOLECULAR CARCINOGENESIS

Clinical trial end points for high-grade glioma: the evolving landscape

(2011) D. A. Reardon et al.   NEURO-ONCOLOGY

Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma: Defining the pancreatic cancer epigenome

(2010) Paul G. Corn   CANCER BIOLOGY & THERAPY

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells.

(2010) Leina Ma et al.   CANCER BIOLOGY & THERAPY

Colon cancer

(2010) Roberto Labianca et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1

(2010) Olga Wesołowska et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

5/35 Fiber-Modified Conditionally Replicative Adenovirus Armed with p53 Shows Increased Tumor-Suppressing Capacity to Breast Cancer Cells

(2010) Xiaoping He et al.   HUMAN GENE THERAPY

Telomeres in cancer and ageing

(2010) L. E. Donate et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Treatment of Cancer with a Novel Dual-Targeted Conditionally Replicative Adenovirus Armed with mda-7/IL-24 Gene

(2008) J. Luo et al.   CLINICAL CANCER RESEARCH

Systemic chemotherapy for cancer: from weapon to treatment

(2008) Heikki Joensuu   LANCET ONCOLOGY